Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
doi:10.1016/j.diabres.2014.01.010
That misses the most important information on the document
A joint investigation by SAHPRA and the South African Pharmacy Council (SAPC) at a pharmacy facility in Pretoria (IDexis) revealed significant regulatory violations
It really puts companies in a difficult spot. Dianne Munevar, head of Healthsperiens center for health, research, policy, and strategy, said that while telehealth companies offering prescription drugs would still fall under FDA jurisdiction, there are regulatory gray areas when these companies offer compounded medications that do not receive FDA approval. Munevar co-authored a study this year on ways to strengthen oversight of drug promotions on social media, suggesting the agency should clarify its regulatory authority under the Federal Food, Drug, and Cosmetic Act with respect to false and misleading advertising of compounded drugs
US$ 24.27
US$ 20.69
US$ 26.73
US$ 26.29
US$ 29.25
US$ 24.44
US$ 27.38
